Читать книгу Anti-Aging Therapeutics Volume XIII - A4M American Academy - Страница 58

REFERENCES

Оглавление

1.Rupprich N, Kindl H. Stilbene synthases and stilbenecarboxylate synthases, I Enzymatic synthesis of 3,5,4-trihydroxystilbene from p-coumaroyl coenzyme A and malonyl coenzyme A. Hoppe Zeylers Z Physiol Chem. 1978;359:165-172.

2.Abe N, Ito T, Ohguchi K, Nasu M, Masuda Y, Oyama M, Nozawa Y, Ito M, Iinuma M. Resveratrol oligomers from Vatica albiramis. J Nat Prod. 2010;73:1499-1506.

3.Micallef M, Lexis L, Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J. 2007;6:27.

4.Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, Chaudhuri A, Dandona P. An anti-inflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cupsidatum containing resveratrol. J Clin Endocrinol Metab. 2010;95:E1-8.

5.Moehrle M, Dietrich H, Patz CD, Häfner HM. Sun protection by red wine? J Dtsch Dermatol Ges. 2009;7:29-32.

6.Baxter R. Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation. J Cosmetic Dermatol. 2008;7:2-7.

7.St Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1017-1020.

8.Ramprasath VR, Jones PJ. Anti-atherogenic effects of resveratrol. Eur J Clin Nutr. 2010;64:660-668.

9.Mokni M, Limam F, Elkahaoui S, Amri M, Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia-reperfusion injury. Arch Biochem Biophys. 2007;457:1-6.

10.Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002;958:439.

11.Zuccala G, Onder G, Pedone C, Cesari M, et al. Intake of flavonoids and risk of dementia. Alcohol Clin Exp Res. 2001;25:1743-1748.

12.Maramboud P, Zhao H, Davies P. Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid beta-peptides. J Biol Chem. 2005;280:37377–37382.

13.Kennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, Haskell CF. Effect of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo controlled, crossover investigation. Am J Clin Nutr. 2010;91:1590-1597.

14.Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E. Inhibition of influenza A virus replication by resveratrol. J Infect Dis. 2005;191:1719-1729.

15.Kraft TE, Parisotto D, Schempp C, Efferth T. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr. 2009;49:782-799.

16.Rezk YA, Balulad SS, Keller RS, Bennett JA. Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and rodent heart. Am J Obstet Gynecol. 2006;194:e23-26.

17.Bessaoud F, Daurés JP, Gerber M. Dietary factors and breast cancer risk: a case-control study among a population in southern France. Nutr Cancer. 2008;60:177-187.

18.Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and red wine, is an agonist for the estrogen receptor. Proc Nat Acad Sci USA. 1997;94:14138-14143.

19.Xia L, Wang XX, Hu XS, Guo XG, Shang YP, Chen HJ, Zeng CL, Zhang FR, Chen JZ. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol. 2008;155:387-394.

20.Palsamy P, Subramanian S. Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Chem Biol Interact. 2009;179:356-362.

21.Guarente L, Picard F. Calorie restriction – the Sir2 connection. Cell 2005;120:473-482.

22.Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191-196.

23.Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang M. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des. 2009;74:619-624.

24.Onken B, Driscoll M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PloS One. 2010;5:e8758.

25.Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N. Disssecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta. 2010;1804:433-439.

26.Vaz da Silva M, Loureiro AI, Falcao A, et al. Effect of food on the pharmacokinetic profile of trans-resveratrol. Int J Clin Pharmacol Ther. 2008;46:564-570.

Anti-Aging Therapeutics Volume XIII

Подняться наверх